Abstract: The invention relates to a process for improving the impact resistance of polyphenylene sulfide (PPS) using a functional polyolefin and an elastomer, in which the functional polyolefin and elastomer are pre-compounded prior to combination with the PPS. The pre-compounding of the PPS additives prior to addition of the additives to the PPS provides a composition having vastly improved impact and strain at break properties. Especially useful functional polyolefins are LOTADER resins (Arkema Inc.) and especially useful elastomers are PEBAX resins (Arkema Inc.).

Abstract: The invention relates to a polyether block amide film, having both resistance to N,N-diethyl-3-methylbenzamide (DEET) insecticide according to MTL-DTL-31011B along with a high level of breathability (>700 g/m2/day) according to ASTM E96 B (50% R.H. & 23° C.). The polyether block polyamides of the invention can be applied to a substrate to produce water barrier, DEET-resistant and breathable apparel.

Abstract: A system and method for analyzing risk for underwriting insurance is provided. The method may comprise: inputting data regarding at least one applicant for insurance, wherein at least one item of data relates to a first category and at least one item of data relates to a second category; assigning a numerical risk factor to at least one item of data; generating a first numerical risk score for the first category; generating a second numerical risk score for the second category; generating a composite risk score based on at least the first numerical risk score and the second numerical risk score; assigning a composite risk score to at least one applicant for insurance; wherein the first category comprises medical conditions or severities of medical conditions and the second category comprises negative medical condition interactions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliamy, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Abstract: Provided herein is a molded vanity top with a surface layer and a composite backing. The backing is made from a polyurethane resin and a filler, which may be any material compatible with the polyurethane resin. The filler is preferably sand and makes-up up to about 85% by weight of the backing. The disclosed vanity tops have the substantial weight and solid sound preferred by consumers, yet are often lighter and stronger than cultured marble vanity tops. Also provided herein is a method of manufacturing a molded vanity top. The interior of a mold is coated with a surface layer. The mold is then filled with a composite backing material made from a polyurethane resin and a filler. After curing, the vanity top is demolded and finished.